Effectiveness of Simeprevir Treatment for Hepatitis C in Real Practice: Preliminary Results from the Stily Italian Observational Study

G.B. Gaeta, Roberta Termini(Apple (Israel)), Sergio Babudieri(University of Sassari), Barbara Menzaghi(Ospedale di Circolo di Busto Arsizio), Alessia Giorgini(Università Cattolica del Sacro Cuore), Maurizia Rossana Brunetto(University of Pisa), S. Fagiuoli(Ospedale Papa Giovanni XXIII), M. Palma(Janssen (Italy)), Gianpiero D’Offizi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), L. Simoni, Adriano Lazzarin(Vita-Salute San Raffaele University)
Journal of Hepatology
January 1, 2016
10.1016/s0168-8278(16)01502-6
Cited by 3

Related Papers

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
|˜The œLancet. Gastroenterology & hepatology|2022|664
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
High rates of 30-day mortality in patients with cirrhosis and COVID-19
|Journal of Hepatology|2020|394
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391